Full-Time
Develops AI-enhanced digital stethoscopes for cardiovascular detection
$95k - $100k/yr
Mid
Oakland, CA, USA
Hybrid position, requiring some in-office presence.
Eko Health specializes in creating advanced medical devices and software to improve the detection of cardiovascular diseases. Their main product is an electronic digital stethoscope that integrates with AI-powered software, helping healthcare professionals identify heart conditions more accurately. The stethoscopes feature Bluetooth connectivity, noise cancellation, and amplification, allowing clinicians to listen wirelessly and clearly. The AI software automatically checks for heart disease indicators, such as atrial fibrillation and heart murmurs, providing reliable results without interrupting the examination process. Eko Health differentiates itself from competitors by combining traditional stethoscope functionality with modern digital enhancements and leveraging a large dataset of real-life heart sounds to train its AI for accurate detection. The company's goal is to enhance early detection and timely intervention in heart and lung diseases, ultimately improving patient outcomes.
Company Size
51-200
Company Stage
Series D
Total Funding
$234.2M
Headquarters
Oakland, California
Founded
2013
Help us improve and share your feedback! Did you find this helpful?
Paid-time off
Medical/Dental/Vision, Disability + Life Insurance
Volunteer time off
One Medical membership
Parental Leave
401(k) Matching
Work from home equipment stipend
Flexible schedules
Wellness programs (Wellness Wednesdays, Time off)
Wellness perks (Headspace, Ginger, Aaptiv, Physera)
Learning and Development stipend
Boehringer Ingelheim and Eko Health Partner to Bring AI-Powered Heart Disease Detection to Veterinary Medicine. by Jasmine Pennic 06/10/2025 Leave a Comment. Source Credit: Boehringer Ingelheim Eko HealthWhat You Should Know: – Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence (AI) for early disease detection, have announced a strategic collaboration. The partnership aims to enhance the early detection and diagnosis of heart disease in dogs by combining Boehringer’s expertise in canine cardiology with Eko Health’s powerful AI algorithms and digital stethoscopes.– The collaboration will leverage Eko Health’s technology, already trusted by healthcare professionals with over 650,000 devices sold for use in human medicine, and combine it with Boehringer’s proprietary algorithm. The result will be a canine-specific detection algorithm made available to veterinarians through a purpose-built Eko mobile app, set to launch in 2026.Addressing a Common Canine Health CrisisHeart murmurs in dogs are a common finding in myxomatous mitral valve disease (MMVD), a chronic heart condition that is a major cause of morbidity and mortality in dogs. MMVD affects approximately 10 to 15% of dogs in their lifetime, making early and accurate detection critical.In a typical clinic visit, veterinarians rely on analog stethoscopes to detect murmurs, often in noisy environments and during time-constrained exams
"By combining Boehringer's global leadership in animal health with Eko's unique ability to deliver advanced detection algorithms to the point of care, we can help millions of pets - and the families who love them - receive the life-extending care they deserve.
Eko Health broadens global reach with UK launch of ai-powered stethoscope platform.
Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, announced the launch of the CORE 500(TM) Digital Stethoscope and Eko+ Membership in Canada.
AVIZVA, a health-tech organization that offers a variety of solutions for healthcare enterprises, that it has appoints James Vertino as its new CEO.Model N appoints Bret Connor as Chief Executive Officer. The Board of Directors of Blue Shield of California appoints Lois Quam as chief executive officer to lead Blue Shield of California, the first woman to serve as CEO in the health plan’s 86-year history. She joined the company as president in 2024. Yaqrit, a late-stage biotech and medtech company developing lifesaving treatments for advanced liver diseases appoints Troels Jordansen has joined Yaqrit as Chief Executive Officer.OP Solutions names Michael Kallish as Chief Executive Officer, effective immediately.Access TeleCare appoints Dr. Michael Genovese to Chief Medical Officer for Behavioral Health.Enveda appoints Jason Kim as Chief Financial Officer (CFO).Eko Health appoints of Justin Spencer as Chief Financial Officer (CFO). (Pull from site)Qure.ai appoints Jim Mercadante as its new Chief Commercial Officer. (Pull from site)Symplr, appoints Dr